Screener
Mirum Pharmaceuticals, Inc. MIRM Change in fair value
Change in fair value at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept mirm:ChangeInFairValueOfHoldbackLiabilities.
The source filing: Mirum Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001759425-26-000045
FAQ
- What is Mirum Pharmaceuticals, Inc.'s change in fair value?
- Mirum Pharmaceuticals, Inc. (MIRM) reported change in fair value of -$12.16M in Q2 2026.
- What does change in fair value mean?
- Change in fair value as reported by Mirum Pharmaceuticals, Inc. Common Stock.
Ask your AI about Mirum Pharmaceuticals, Inc.'s change in fair value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude